Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:06 PM
Ignite Modification Date:
2025-12-24 @ 2:06 PM
NCT ID:
NCT06128395
Eligibility Criteria:
Inclusion Criteria:
* Women taking aspirin 81 mg or 162 mg prior to an autologous embryo transfer
* Age \< 40 years old
* Embryo transfer cycle done at clinique ovo
Exclusion Criteria:
* Egg or embryo recipient
* History of recurrent miscarriages, defined as ≥ 3 consecutive losses
* Patients that needed Viagra, PRP or other modalities to improve their endometrial thickness
* Uterine factor infertility
* Abnormal hormonal profiles
* Stimulated embryo transfer cycles
* History of recurrent implantation failure defined as failed ≥ 2 euploid embryos transfer or ≥ 3 blastocysts
Sex:
FEMALE
Maximum Age:
40 Years
Study:
NCT06128395
Study Brief:
Protocol Section:
NCT06128395